摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

{2-[4-(4-fluoro-phenyl)-5-pyridin-4-yl-oxazol-2-yl]-5-methyl-[1,3]dioxan-5-yl}-morpholin-4-yl-methanone | 1100597-92-9

中文名称
——
中文别名
——
英文名称
{2-[4-(4-fluoro-phenyl)-5-pyridin-4-yl-oxazol-2-yl]-5-methyl-[1,3]dioxan-5-yl}-morpholin-4-yl-methanone
英文别名
[2-[4-(4-Fluorophenyl)-5-pyridin-4-yl-1,3-oxazol-2-yl]-5-methyl-1,3-dioxan-5-yl]-morpholin-4-ylmethanone
{2-[4-(4-fluoro-phenyl)-5-pyridin-4-yl-oxazol-2-yl]-5-methyl-[1,3]dioxan-5-yl}-morpholin-4-yl-methanone化学式
CAS
1100597-92-9
化学式
C24H24FN3O5
mdl
——
分子量
453.47
InChiKey
YDLAAOGLKIUPGS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    33
  • 可旋转键数:
    4
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    86.9
  • 氢给体数:
    0
  • 氢受体数:
    8

文献信息

  • Heteroaryl-cyclic acetals
    申请人:Collis Alan
    公开号:US20050090501A1
    公开(公告)日:2005-04-28
    Compounds of formula (I) are described in which Het is a five or six membered heteroaromatic ring of the formula in which one of R 1 and R 2 is optionally substituted heteroaryl and the other is optionally substituted heteroaryl or optionally substituted aryl; X 1 is a bond, X 3 and X 4 are each independently N or C and X 2 and X 5 are independently CH, N, NH, O or S; or X 3 and X 4 are C, one of X 1 , X 2 and X 5 is N and the others are N or CH; but excluding compounds in which X 1 is a bond, one of X 2 and X 5 is N and the other is NH and X 3 and X 4 are both C; R 3 represents a group -L 1 -R 6 ; R 4 represents hydrogen, alkyl or hydroxyalkyl; or R 3 and R 4 , when attached to the same carbon atom, may form with the said carbon atom a cycloalkyl, cycloalkenyl or heterocycloalkyl ring or a group C═CH 2 ; R 5 represents hydrogen or alkyl; and m is zero or an integer 1 or 2; and N-oxides thereof, and their prodrugs; and pharmaceutically acceptable salts and solvates of compounds of formula (I) and N-oxides thereof, and their prodrugs. The compounds are TNF inhibitors and are useful as pharmaceuticals.
    描述了式(I)化合物,其中Het是式的五元或六元杂环芳香环:其中R1和R2中的一个是可选取代的杂芳基,另一个是可选取代的杂芳基或可选取代的芳基;X1是键,X3和X4分别独立地是N或C,X2和X5独立地是CH、N、NH、O或S;或者X3和X4是C,X1、X2和X5中的一个是N,其他是N或CH;但不包括其中X1是键,X2和X5中的一个是N,另一个是NH,X3和X4都是C的化合物;R3表示一个-L1-R6基团;R4表示氢、烷基或羟基烷基;或者当附加到同一个碳原子时,R3和R4可以与所述碳原子形成环状烷基、环状烯基或杂环烷基环或C═CH2基团;R5表示氢或烷基;m为零或整数1或2;以及其N-氧化物和其前药;化合物的式(I)和其N-氧化物的药学上可接受的盐和溶剂;这些化合物是TNF抑制剂,可用于制药。
  • HETEROARYL-CYCLIC ACETALS
    申请人:Aventis Pharma Limited
    公开号:EP1140916B1
    公开(公告)日:2002-11-13
  • US7479501B2
    申请人:——
    公开号:US7479501B2
    公开(公告)日:2009-01-20
查看更多